Inicio › Cánceres de la sangre › Nueva York

Ensayos clínicos de Cánceres de la sangre en Nueva York

29 estudios sobre Cánceres de la sangre buscan participantes en Nueva York.

Ciudades en Nueva York

Texto oficial del estudio (inglés)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York
White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

NYU Langone Health, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07572006

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Mount Sinai Medical Center, New York
University of Rochester Medical Center, Rochester

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04634552

Genomic Profiling in Cancer Patients

Kings County Hopsital Center, Brooklyn
Memorial Sloan Kettering Cancer Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
y 7 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 24 sept 2026 · NCT01775072

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 4, Buffalo
Quetzal Site 2, The Bronx

ReclutandoFase 3

Edades de 18 a 71 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07504458

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
y 1 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT03816345

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

David H. Koch Center for Cancer Care, New York
Montefiore Medical Center PRIME, The Bronx

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematology Oncology Associates of Central New York-Auburn, Auburn
Roswell Park Cancer Institute, Buffalo
Hematology Oncology Associates of CNY at Camillus, Camillus
y 5 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 17 sept 2026 · NCT04242095

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07195916

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Research Site, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT07220616

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

State University of New York at Buffalo, Buffalo
Icahn School of Medicine at Mount Sinai, New York
Columbia University, New York
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Comprehensive Cancer Center, Buffalo
Northwell Health, LLC PRIME, Lake Success
Memorial Sloan Kettering Cancer Center, New York
y 3 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Northwell Health, Manhasset
NYP/Weill Cornell Medical Center, New York

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT04515810

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
y 1 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Roswell Park Cancer Institute, Buffalo
North Shore University Hospital, Lake Sucess
Cohen Children's Medical Center of New York, New Hyde
y 9 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
New York University (Data Collection Only), New York
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT07006506

IVIG for Infection Prevention After CAR-T-Cell Therapy

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT05952804

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

New York Presbyterian Hospital, New York
Mt Sinai Medical Center, New York

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT06401356

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Mount Sinai Hospital, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 jun 2026 · NCT05663502

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
y 1 más

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 26 may 2026 · NCT07052916

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Roswell Park Comprehensive Cancer Center, Buffalo
Mt Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 abr 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Roswell Park Comprehensive Cancer Center, Buffalo
New York - Presbyterian / Weill Cornell Medicine, New York
Mount Sinai - Ruttenberg Treatment Center, New York
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT05735184

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Memorial Sloan Kettering Cancer Center, New York

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 ene 2026 · NCT07362225

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

ReclutandoFase 1

Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Memorial Sloan Kettering Cancer Center (MSKCC), New York

ReclutandoFase 1/2

Todas las edades · Todos los sexos · Actualizado el 6 mar 2023 · NCT04959903

The Leukemia and Lymphoma Society (LLS) National Research Registry

Lymphoma and Leukemia Society, Rye Brook

ReclutandoEstudio observacional

Edades de 21 en adelante · Todos los sexos · Actualizado el 7 abr 2022 · NCT04806295

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.